Biomarker and testing questions

Ask which EGFR mutation was found, whether resistance testing is needed, and whether brain imaging changes the plan.

Second-opinion questions

Does the molecular report support this drug, and should a lung cancer specialist review sequencing options?

Safety discussion reminder

Targeted therapies have drug-specific risks and interactions. Review the official label with the oncology team.

Official source links